This Article Full Text Full Text (PDF) A correction has been published Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by New, M. I. Search for Related Content PubMed PubMed Citation Articles by New, M. I. Related Collections Adrenal and Hypertension Neuroendocrinology and Pituitary Pediatric Endocrinology

Nonclassical 21-Hydroxylase Deficiency

Department of Pediatrics, Mount Sinai School of Medicine, New York, New York 10029

Address all correspondence and requests for reprints to: Dr. Maria I. New, Director, Adrenal Steroid Disorders Program, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1198, New York, New York 10029. E-mail: maria.new{at}mssm.edu.

Context: Nonclassical congenital adrenal hyperplasia (CAH) owing to steroid 21-hydroxylase deficiency (NC21OHD) is the most frequent of all autosomal recessive genetic diseases, occurring in one in 100 persons in the heterogeneous New York City population. NC21OHD occurs with increased frequency in certain ethnic groups, such as Ashkenazi Jews, in whom one in 27 express the disease. NC21OHD is underdiagnosed in both male and female patients with hyperandrogenic symptoms because hormonal abnormalities in NC21OHD are only mild to moderate, not severe as in the classical form of CAH. Unlike classical CAH, NC21OHD is not associated with ambiguous genitalia of the newborn female.

Main Outcome Measures: The hyperandrogenic symptoms include advanced bone age, early pubic hair, precocious puberty, tall stature, and early arrest of growth in children; infertility, cystic acne, and short stature in both adult males and females; hirsutism, frontal balding, polycystic ovaries, and irregular menstrual periods in females; and testicular adrenal rest tissue in males.

Conclusions: The signs and symptoms of hyperandrogenism are reversed with dexamethasone treatment.

This article has been cited by other articles:

				M. Hickey, D. M. Sloboda, H. C. Atkinson, D. A. Doherty, S. Franks, R. J. Norman, J. P. Newnham, and R. Hart The Relationship between Maternal and Umbilical Cord Androgen Levels and Polycystic Ovary Syndrome in Adolescence: A Prospective Cohort Study J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3714 - 3720. [Abstract] [Full Text] [PDF]

				P. Cavarzere, D. Samara-Boustani, I. Flechtner, M. Dechaux, C. Elie, V. Tardy, Y. Morel, and M. Polak Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia Eur. J. Endocrinol., August 1, 2009; 161(2): 285 - 292. [Abstract] [Full Text] [PDF]

				J.-B. Armengaud, M.-L. Charkaluk, C. Trivin, V. Tardy, G. Breart, R. Brauner, and M. Chalumeau Precocious Pubarche: Distinguishing Late-Onset Congenital Adrenal Hyperplasia from Premature Adrenarche J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2835 - 2840. [Abstract] [Full Text] [PDF]

				M. Bidet, C. Bellanne-Chantelot, M.-B. Galand-Portier, V. Tardy, L. Billaud, K. Laborde, C. Coussieu, Y. Morel, C. Vaury, J.-L. Golmard, et al. Clinical and Molecular Characterization of a Cohort of 161 Unrelated Women with Nonclassical Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and 330 Family Members J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1570 - 1578. [Abstract] [Full Text] [PDF]

				A. Balestrieri, L. Zirilli, B. Madeo, E. Pignatti, G. Rossi, C. Carani, and V. Rochira 21-Hydroxylase Deficiency and Klinefelter Syndrome in an Adult Man: Striking a Balance Between Androgen Excess and Insufficiency J Androl, November 1, 2008; 29(6): 605 - 609. [Full Text] [PDF]

				F. G. Riepe, O. Hiort, J. Grotzinger, W. G. Sippell, N. Krone, and P.-M. Holterhus Functional and Structural Consequences of a Novel Point Mutation in the CYP21A2 Gene Causing Congenital Adrenal Hyperplasia: Potential Relevance of Helix C for P450 Oxidoreductase-21-Hydroxylase Interaction J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2891 - 2895. [Abstract] [Full Text] [PDF]

				R. S. Araujo, B. B. Mendonca, A. S. Barbosa, C. J. Lin, J. A. M. Marcondes, A. E. C. Billerbeck, and T. A. S. S. Bachega Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4028 - 4034. [Abstract] [Full Text] [PDF]